Pure Global
NCT06363864

Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

Investigation of Metabolite Differences Between Taiwanese Metabolic Syndrome and Healthy Group Through Metabolomics
Leeuwenhoek Laboratories Co. Ltd.·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Metabolic Syndrome
Study type
Observational
Sponsor & location
Primary sponsor
Leeuwenhoek Laboratories Co. Ltd.
Timeline & enrollment
Phase
N/A
Start date
Apr 14, 2024
End date
Oct 31, 2029
Enrollment
1200 participants
Primary outcome

Concentration changes of small molecules in blood.

Summary

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project,
 the database of blood test results from healthy and metabolic syndromes individuals will be
 analyzed to identify the small molecules related to the severity of metabolic syndrome. These
 identified small molecules could be used as biomarkers to predict the development of
 metabolic syndromes in the future.

ICD-10 classifications
Metabolic disordersMetabolic disorder, unspecifiedOther metabolic disordersOther specified metabolic disordersNutritional and metabolic disorders in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06363864
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06363864 through Pure Global AI's free database. This phase not specified trial is sponsored by Leeuwenhoek Laboratories Co. Ltd. and is currently Not yet recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 1200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.